Log In
Print
BCIQ
Print
Print this Print this
 

NKTR-214

  Manage Alerts
Collapse Summary General Information
Company Nektar Therapeutics
DescriptionImmunostimulatory cytokine engineered to selectively activate IL-2 receptors on cytotoxic T cells
Molecular Target
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today